Dapagliflozin Improves Glycemic Control, Hypertension and is Neutral on Severe Renal Impairment in Uni-nephrectomized SDT fatty rat, a 10-week Model of Advanced Renal Complications and Glomerular Filtration Rate Decline.

Key Word:
Dapagliflozin (ダパグリフロジン), Glycemic Control (血糖コントロール), Hypertension (高血圧), Renal Impairment (腎機能障害), Uni-nephrectomized (片腎摘出), Renal Complications (腎合併症), Glomerular Filtration Rate (糸球体濾過率)

François Briand¹, Masami Shinohara², Emmanuel Brousseau¹, Yasushi Kageyama², Thierry Sulpice¹

¹Physiogenex, Labège, France; ²CLEA Japan Inc. Meguro-ku, Tokyo, Japan

For more details, please click here (Google Search)

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

 https://www.clea-japan.com/products/diabetes/item_a0150

Inquiry（お問い合わせ）

If you have any questions, please feel free to contact us.